Advertisement

Effectiveness of different treatments for odontogenic keratocyst: a network meta-analysis

Published:September 20, 2022DOI:https://doi.org/10.1016/j.ijom.2022.09.004

      Abstract

      Odontogenic keratocysts (OKC) are benign but aggressive lesions. As there is a lack of well randomized clinical studies assessing the effectiveness of the different treatment options for OKC, a network meta-analysis (NMA) was performed to identify the best treatment option with the lowest recurrence rate. An electronic search was performed following the PRISMA guidelines to identify all clinical studies comparing treatment options against enucleation alone. The outcome variable was recurrence. The predictor variables were treatments. The eight included treatments were: enucleation with peripheral ostectomy/curettage (E + PO/curettage); enucleation with cryotherapy (E + CRYO); enucleation with/without PO followed by modified Carnoy’s solution (E ± PO+MCS); enucleation with PO and with topical 5-fluorouracil (E + PO+5FU); enucleation with/without PO followed by original Carnoy’s solution (E ± PO+CS); marsupialization alone (MARS); marsupialization followed by secondary enucleation with/without PO (MARS+2°E ± PO); and resection. The odds ratio was used to estimate the recurrence rate. A frequentist NMA was performed using Stata software. A total of 2989 patients in 40 studies were included. Both direct pairwise meta-analysis and NMA showed that E + 5FU+PO was significantly superior to E ± PO+MCS. However, no statistically significant difference was found between E ± PO+CS vs E + 5FU+PO, E ± PO+MCS, and resection, respectively (all very low quality evidence). The three most effective treatments in reducing the recurrence rate were E + PO+ 5FU (98.1%; very low quality evidence), resection (83.5%; very low quality evidence), and E ± PO+CS (63.8%; moderate quality evidence). The findings from this study suggest that CS remains the most effective fixative agent after enucleation and PO until proven otherwise. Additionally, 5FU appears to be an effective method with promising results that needs further research. Finally, the efficacy of MCS remains controversial; further in vivo and in vitro studies are required to determine new protocols. As this NMA included retrospective studies, the results should be interpreted with great caution (level of evidence: type III).

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sharif F.
        • Oliver R.
        • Sweet C.
        • Sharif M.O.
        Interventions for the treatment of keratocystic odontogenic tumours (KCOT, odontogenic keratocysts (OKC)).
        Cochrane Database Syst Rev. 2010; 9CD008464
        • de Castro M.S.
        • Caixeta C.A.
        • de Carli M.L.
        • Ribeiro Junior N.V.
        • Miyazawa M.
        • Pereira A.A.C.
        • Sperandio F.F.
        • Hanemann J.A.C.
        Conservative surgical treatments for nonsyndromic odontogenic keratocysts: a systematic review and meta-analysis.
        Clin Oral Investig. 2018; 22: 2089-2101
        • Al-Moraissi E.A.
        • Dahan A.A.
        • Alwadeai M.S.
        • Oginni F.O.
        • Al-Jamali J.M.
        • Alkhutari A.S.
        • Al-Tairi N.H.
        • Almaweri A.A.
        • Al-Sanabani J.S.
        What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor? A large systematic review and meta-analysis.
        J Craniomaxillofac Surg. 2017; 45: 131-144
        • Tabrizi R.
        • Hosseini Kordkheili M.R.
        • Jafarian M.
        • Aghdashi F.
        Decompression or marsupialization; which conservative treatment is associated with low recurrence rate in keratocystic odontogenic tumors? A systematic review.
        J Dent. 2019; 20: 145-151
        • Chrcanovic B.R.
        • Gomez R.S.
        Recurrence probability for keratocystic odontogenic tumors: an analysis of 6427 cases.
        J Craniomaxillofac Surg. 2017; 45: 244-251
        • Dashow J.E.
        • McHugh J.B.
        • Braun T.M.
        • Edwards S.P.
        • Helman J.I.
        • Ward B.B.
        Significantly decreased recurrence rates in keratocystic odontogenic tumor with simple enucleation and curettage using Carnoy’s versus modified Carnoy’s solution.
        J Oral Maxillofac Surg. 2015; 73: 2132-2135
        • Zhao Y.F.
        • Wei J.X.
        • Wang S.P.
        Treatment of odontogenic keratocysts: a follow-up of 255 Chinese patients.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 94: 151-156
        • Chirapathomsakul D.
        • Sastravaha P.
        • Jansisyanont P.
        A review of odontogenic keratocysts and the behavior of recurrences.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101: 5-9
        • Stoelinga P.J.
        Long-term follow-up on keratocysts treated according to a defined protocol.
        Int J Oral Maxillofac Surg. 2001; 30: 14-25
        • Johnson N.R.
        • Gannon O.M.
        • Savage N.W.
        • Batstone M.D.
        Frequency of odontogenic cysts and tumors: a systematic review.
        J Investig Clin Dent. 2014; 5: 9-14
        • Donnelly L.A.
        • Simmons T.H.
        • Blitstein B.J.
        • Pham M.H.
        • Saha P.T.
        • Phillips C.
        • White R.P.
        • Blakey G.H.
        Modified Carnoy’s compared to Carnoy’s solution is equally effective in preventing recurrence of odontogenic keratocysts.
        J Oral Maxillofac Surg. 2021; 79: 1874-1881
        • Longley D.B.
        • Harkin D.P.
        • Johnston P.G.
        5-fluorouracil: mechanisms of action and clinical strategies.
        Nat Rev Cancer. 2003; 3: 330-338
        • Ledderhof N.J.
        • Caminiti M.F.
        • Bradley G.
        • Lam D.K.
        Topical 5-fluorouracil is a novel targeted therapy for the keratocystic odontogenic tumor.
        J Oral Maxillofac Surg. 2017; 75: 514-524
        • Caminiti M.F.
        • El-Rabbany M.
        • Jeon J.
        • Bradley G.
        5-Fluorouracil is associated with a decreased recurrence risk in odontogenic keratocyst management: a retrospective cohort study.
        J Oral Maxillofac Surg. 2021; 79: 814-821
        • Akhter Lone P.
        • Ahmed Wani N.
        • Ahmed Janbaz Z.
        • Bibi M.
        • Kour A.
        Topical 5-fluorouracil application in management of odontogenic keratocysts.
        J Oral Biol Craniofac Res. 2020; 10: 404-406
        • Rothwell P.M.
        External validity of randomised controlled trials: “to whom do the results of this trial apply?”.
        Lancet. 2005; 365: 82-93
        • Hutton B.
        • Salanti G.
        • Caldwell D.M.
        • Chaimani A.
        • Schmid C.H.
        • Cameron C.
        • Ioannidis J.P.
        • Straus S.
        • Thorlund K.
        • Jansen J.P.
        • Mulrow C.
        • Catalá-López F.
        • Gøtzsche P.C.
        • Dickersin K.
        • Boutron I.
        • Altman D.G.
        • Moher D.
        The PRISMA Extension Statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
        Ann Intern Med. 2015; 162: 777-784
        • Wells G.A.
        • Shea B.
        • O’Connell D.
        • Peterson J.
        • Welch V.
        • Losos M.
        • Tugwell P.
        The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses.
        Ottawa Hospital Research Institute, 2014
        • Salanti G.
        • Kavvoura F.K.
        • Ioannidis J.P.
        Exploring the geometry of treatment networks.
        Ann Intern Med. 2008; 148: 544-553
        • StataCorp
        Stata Statistical Software: Release 15.
        StataCorp LLC, College Station, TX2017
        • White I.R.
        Network meta-analysis.
        Stata J. 2015; 15: 951-985
        • Higgins J.P.
        • Jackson D.
        • Barrett J.K.
        • Lu G.
        • Ades A.E.
        • White I.R.
        Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies.
        Res Synth Methods. 2012; 3: 98-110
        • White I.R.
        • Barrett J.K.
        • Jackson D.
        • Higgins J.P.
        Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression.
        Res Synth Methods. 2012; 3: 111-125
        • Salanti G.
        • Ades A.E.
        • Ioannidis J.P.
        Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.
        J Clin Epidemiol. 2011; 64: 163-171
        • Veroniki A.A.
        • Bender R.
        • Glasziou P.
        • Straus S.E.
        • Tricco A.C.
        The number needed to treat in pairwise and network meta-analysis and its graphical representation.
        J Clin Epidemiol. 2019; 111: 11-22
        • Macaskill P.
        • Walter S.D.
        • Irwig L.
        A comparison of methods to detect publication bias in meta-analysis.
        Stat Med. 2001; 20: 641-654
        • Voorsmit R.A.
        • Stoelinga P.J.
        • van Haelst U.J.
        The management of keratocysts.
        J Maxillofac Surg. 1981; 9: 228-236
        • Jensen J.
        • Sindet-Pedersen S.
        • Simonsen E.K.
        A comparative study of treatment of keratocysts by enucleation or enucleation combined with cryotherapy. A preliminary report.
        J Craniomaxillofac Surg. 1988; 16: 362-365
        • Brøndum N.
        • Jensen V.J.
        Recurrence of keratocysts and decompression treatment. A long-term follow-up of forty-four cases.
        Oral Surg Oral Med Oral Pathol. 1991; 72: 265-269
        • Chow H.T.
        Odontogenic keratocyst: a clinical experience in Singapore.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86: 573-577
        • Morgan T.A.
        • Burton C.C.
        • Qian F.
        A retrospective review of treatment of the odontogenic keratocyst.
        J Oral Maxillofac Surg. 2005; 63: 635-639
        • Maurette P.E.
        • Jorge J.
        • de Moraes M.
        Conservative treatment protocol of odontogenic keratocyst: a preliminary study.
        J Oral Maxillofac Surg. 2006; 64: 379-383
        • Driemel O.
        • Rieder J.
        • Morsczeck C.
        • Schwarz S.
        • Hakim S.G.
        • Müller-Richter U.
        • Reichert T.E.
        • Kosmehl H.
        Comparison of clinical immunohistochemical findings in keratocystic odontogenic tumours and ameloblastomas considering their risk of recurrence.
        Mund Kiefer Gesichtschir. 2007; 11: 221-231
        • Kolokythas A.
        • Fernandes R.P.
        • Pazoki A.
        • Ord R.A.
        Odontogenic keratocyst: to decompress or not to decompress? A comparative study of decompression and enucleation versus resection/peripheral ostectomy.
        J Oral Maxillofac Surg. 2007; 65: 640-644
        • Madras J.
        • Lapointe H.
        Keratocystic odontogenic tumour: reclassification of the odontogenic keratocyst from cyst to tumour.
        J Can Dent Assoc. 2008; 74165-h
        • Boffano P.
        • Ruga E.
        • Gallesio C.
        Keratocystic odontogenic tumor (odontogenic keratocyst): preliminary retrospective review of epidemiologic, clinical, and radiologic features of 261 lesions from University of Turin.
        J Oral Maxillofac Surg. 2010; 68: 2994-2999
        • Zecha J.A.
        • Mendes R.A.
        • Lindeboom V.B.
        • van der Waal I.
        Recurrence rate of keratocystic odontogenic tumor after conservative surgical treatment without adjunctive therapies—a 35-year single institution experience.
        Oral Oncol. 2010; 46: 740-742
        • Gosau M.
        • Draenert F.G.
        • Muller S.
        • Frerich B.
        • Burgers R.
        • Reichert T.E.
        • Driemel O.
        Two modifications in the treatment of keratocystic odontogenic tumors (KCOT) and the use of Carnoy’s solution (CS)—a retrospective study lasting between 2 and 10 years.
        Clin Oral Investig. 2010; 14: 27-34
        • Schussel J.L.
        • Stramandinoli R.T.
        • Dissenha J.L.
        • Avila L.F.
        • Sassi L.M.
        Retrospective study of 25 cases of keratocystic odontogenic tumor: epidemiology and treatment.
        J Contemp Dent Pract. 2011; 12: 100-103
        • Zhao Y.
        • Liu B.
        • Cheng G.
        • Wang S.P.
        • Wang Y.N.
        Recurrent keratocystic odontogenic tumours: report of 19 cases.
        Dentomaxillofac Radiol. 2012; 41: 96-102
        • Guler N.
        • Sencift K.
        • Demirkol O.
        Conservative management of keratocystic odontogenic tumors of jaws.
        Sci World J. 2012; 2012680397
        • Selvi F.
        • Tekkesin M.S.
        • Cakarer S.
        • Isler S.C.
        • Keskin C.
        Keratocystic odontogenic tumors: predictive factors of recurrence by Ki-67 and AgNOR labelling.
        Int J Med Sci. 2012; 9: 262-268
        • Tabrizi R.
        • Ozkan B.T.
        • Dehgani A.
        • Langner N.J.
        Marsupialization as a treatment option for the odontogenic keratocyst.
        J Craniofac Surg. 2012; 23: e459-e461
        • MacDonald D.
        • Gu Y.
        • Zhang L.
        • Poh C.
        Can clinical and radiological features predict recurrence in solitary keratocystic odontogenic tumors?.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 115: 263-271
        • Sanchez-Burgos R.
        • Gonzalez-Martin-Moro J.
        • Perez-Fernandez E.
        • Burgueno-Garcia M.
        Clinical, radiological and therapeutic features of keratocystic odontogenic tumours: a study over a decade.
        J Clin Exp Dent. 2014; 6: e259-e264
        • Levorova J.
        • Machon V.
        • Grill P.
        • Hirjak D.
        • Foltan R.
        Keratocystic odontogenic tumour with extraosseal spread: evaluation of the effect Carnoy’s solution.
        Prague Med Rep. 2015; 116: 303-313
        • Gupta A.
        • Bansal P.
        • Sharma R.
        • Sharma S.D.
        Treatment of keratocystic odontogenic tumours: a prospective study of 30 cases.
        J Maxillofac Oral Surg. 2016; 15: 521-527
        • Berge T.I.
        • Helland S.B.
        • Sælen A.
        • Øren M.
        • Johannessen A.C.
        • Skartveit L.
        • Grung B.
        Pattern of recurrence of nonsyndromic keratocystic odontogenic tumors.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 122: 10-16
        • Cunha J.F.
        • Gomes C.C.
        • de Mesquita R.A.
        • Andrade Goulart E.M.
        • de Castro W.H.
        • Gomez R.S.
        Clinicopathologic features associated with recurrence of the odontogenic keratocyst: a cohort retrospective analysis.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 121: 629-635
        • Awni S.
        • Conn B.
        Decompression of keratocystic odontogenic tumors leading to increased fibrosis, but without any change in epithelial proliferation.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2017; 123: 634-644
        • Daroit N.B.
        • da Rocha Vieira R.
        • Visioli F.
        • Maito F.D.M.
        • de Oliveira M.G.
        • Rados P.V.
        Does surgical fragmentation of odontogenic keratocystic capsule interfere with the recurrence rate?.
        J Oral Maxillofac Surg. 2018; 76: 770-774
        • Naruse T.
        • Yamashita K.
        • Yanamoto S.
        • Rokutanda S.
        • Matsushita Y.
        • Sakamoto Y.
        • Sakamoto H.
        • Ikeda H.
        • Ikeda T.
        • Asahina I.
        • Umeda M.
        Histopathological and immunohistochemical study in keratocystic odontogenic tumors: predictive factors of recurrence.
        Oncol Lett. 2017; 13: 3487-3493
        • Kinard B.
        • Hansen G.
        • Newman M.
        • Dennis P.
        • Haeffs T.
        • Perez S.
        • Hamao-Sakamoto A.
        • Steed M.
        • Hughes P.
        • August M.
        • Abramowicz S.
        How well do we manage the odontogenic keratocyst? A multicenter study.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2019; 127: 282-288
        • Ege B.
        • Demirkol M.
        • Yalcin M.
        • Alan H.
        Clinical and radiographic features of odontogenic keratocysts and evaluation of recurrence rates after treatment: a retrospective study.
        Ann Med Res. 2021; 26: 1951-1957
        • Motaleb L.
        • Zakai D.
        • Stocker J.
        Fourteen-year study of the management of the odontogenic keratocyst. Are adjunctive therapies all they are cut out to be?.
        Br J Oral Maxillofac Surg. 2022; 60: 105-112
        • Borges L.B.O.
        • Almeida R.S.
        • Da Silva R.A.
        • Sato F.R.L.
        Retrospective study of therapeutic approaches, recurrence and prevalence of cases of odontogenic keratocysts at a general hospital.
        Adv Oral Maxillofac Surg. 2021; 2100047
        • Mohanty S.
        • Dabas J.
        • Verma A.
        • Gupta S.
        • Urs A.B.
        • Hemavathy S.
        Surgical management of the odontogenic keratocyst: a 20-year experience.
        Int J Oral Maxillofac Surg. 2021; 50: 1168-1176
        • Boffano P.
        • Cavarra F.
        • Agnone A.M.
        • Brucoli M.
        • Ruslin M.
        • Forouzanfar T.
        • Ridwan-Pramana A.
        • Rodríguez-Santamarta T.
        • de Vicente J.C.
        • Starch-Jensen T.
        • Pechalova P.
        • Pavlov N.
        • Doykova I.
        • Gospodinov D.
        • Konstantinovic V.S.
        • Jovanović M.
        • Barrabé A.
        • Louvrier A.
        • Meyer C.
        • Tamme T.
        • Andrianov A.
        • Dovšak T.
        • Birk A.
        • Masu L.
        • Rocchetti V.
        The epidemiology and management of odontogenic keratocysts (OKCs): a European multicenter study.
        J Craniomaxillofac Surg. 2022; 50: 1-6
        • Titinchi F.
        • Nortje C.J.
        Keratocystic odontogenic tumor: a recurrence analysis of clinical and radiographic parameters.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 114: 136-142
        • Blanas N.
        • Freund B.
        • Schwartz M.
        • Furst I.M.
        Systematic review of the treatment and prognosis of the odontogenic keratocyst.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 90: 553-558
        • Antonoglou G.N.
        • Sandor G.K.
        • Koidou V.P.
        • Papageorgiou S.N.
        Non-syndromic and syndromic keratocystic odontogenic tumors: systematic review and meta-analysis of recurrences.
        J Craniomaxillofac Surg. 2014; 42: e364-e371
        • Slusarenko da Silva Y.
        • Stoelinga P.J.W.
        • Naclerio-Homem M.D.G.
        Recurrence of nonsyndromic odontogenic keratocyst after marsupialization and delayed enucleation vs. enucleation alone: a systematic review and meta-analysis.
        Oral Maxillofac Surg. 2019; 23: 1-11
        • Oginni F.O.
        • Alasseri N.
        • Ogundana O.M.
        • Famurewa B.A.
        • Pogrel A.
        • Al-Moraissi E.A.
        An evidence-based surgical algorithm for management of odontogenic keratocyst.
        Oral Maxillofac Surg. 2022; (Online ahead of print)
        • Brannon R.B.
        The odontogenic keratocyst. A clinicopathologic study of 312 cases. Part I. Clinical features.
        Oral Surg Oral Med Oral Pathol. 1976; 42: 54-72
        • Gaitan-Cepeda L.A.
        • Quezada-Rivera D.
        • Tenorio-Rocha F.
        • Leyva-Huerta E.R.
        Reclassification of odontogenic keratocyst as tumour. Impact on the odontogenic tumours prevalence.
        Oral Dis. 2010; 16: 185-187
        • Jaeger F.
        • de Noronha M.S.
        • Silva M.L.
        • Amaral M.B.
        • Grossmann S.M.
        • Horta M.C.
        • de Souza P.E.
        • de Aguiar M.C.
        • Mesquita R.A.
        Prevalence profile of odontogenic cysts and tumors on Brazilian sample after the reclassification of odontogenic keratocyst.
        J Craniomaxillofac Surg. 2017; 45: 267-270
        • Macdonald-Jankowski D.S.
        Glandular odontogenic cyst: systematic review.
        Dentomaxillofac Radiol. 2010; 39: 127-139
        • Rud J.
        • Pindborg J.J.
        Odontogenic keratocysts: a follow-up study of 21 cases.
        J Oral Surg. 1969; 27: 323-330
        • Kaczmarzyk T.
        • Mojsa I.
        • Stypulkowska J.
        A systematic review of the recurrence rate for keratocystic odontogenic tumour in relation to treatment modalities.
        Int J Oral Maxillofac Surg. 2012; 41: 756-767
        • Pitak-Arnnop P.
        • Chaine A.
        • Oprean N.
        • Dhanuthai K.
        • Bertrand J.C.
        • Bertolus C.
        Management of odontogenic keratocysts of the jaws: a ten-year experience with 120 consecutive lesions.
        J Craniomaxillofac Surg. 2010; 38: 358-364
        • Ribeiro-Junior O.
        • Borba A.M.
        • Alves C.A.F.
        • Gouveia M.M.
        • Deboni M.C.Z.
        • Naclerio-Homem M.D.G.
        Reclassification and treatment of odontogenic keratocysts: a cohort study.
        Braz Oral Res. 2017; 31e98
        • Pogrel M.A.
        Treatment of keratocysts: the case for decompression and marsupialization.
        J Oral Maxillofac Surg. 2005; 63: 1667-1673
        • Ribeiro Junior O.
        • Borba A.M.
        • Alves C.A.
        • de Gouveia M.M.
        • Coracin F.L.
        • Guimaraes Junior J.
        Keratocystic odontogenic tumors and Carnoy’s solution: results and complications assessment.
        Oral Dis. 2012; 18: 548-557
        • Frerich B.
        • Cornelius C.P.
        • Wietholter H.
        Critical time of exposure of the rabbit inferior alveolar nerve to Carnoy’s solution.
        J Oral Maxillofac Surg. 1994; 52: 599-606
        • Hellstein J.
        • Hopkins T.
        • Morgan T.
        The history and mystery of Carnoy solution: an assessment of the need for chloroform.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103e24
        • Whittaker D.K.
        Mechanisms of tissue destruction following cryosurgery.
        Ann R Coll Surg Engl. 1984; 66: 313-318
        • Tay Z.W.
        • Sue W.L.
        • Leeson R.M.A.
        Chemical adjuncts and cryotherapy in the management of odontogenic keratocysts: a systematic review.
        Adv Oral Maxillofac Surg. 2021; 3100116
        • Wang Q.
        • Huang S.
        • Yang L.
        • Zhao L.
        • Yin Y.
        • Liu Z.
        • Chen Z.
        • Zhang H.
        Down-regulation of Sonic Hedgehog signaling pathway activity is involved in 5-fluorouracil-induced apoptosis and motility inhibition in Hep3B cells.
        Acta Biochim Biophys Sin. 2008; 40: 819-829
        • Metelli S.
        • Chaimani A.
        Challenges in meta-analyses with observational studies.
        Evid Based Ment Health. 2020; 23: 83-87